Health Condition 1: null- Chronic Kidney Disease patients on maintenance hemodialysis
Conditions
Interventions
Intervention1: Genotype based dose of Tacrolimus: Oral, Genotype based dose of Tacrolimus calculated as per weight of patient for one year, twice a day.
Control Intervention1: Standard dose of Tacroli
Sponsors
AIIMS Research Grant
Eligibility
Inclusion criteria
Inclusion criteria: Patients being planned for renal transplant surgery
Exclusion criteria
Exclusion criteria: ABO incompatible and deceased renal transplant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The graft outcome will be assessed in terms of acute cellular rejection, acute antibody mediated rejection, calcineurin inhibitor toxicity, unexplained rise in serum creatinine, hypertension, hyperglycemia and opportunistic infection. The time to achieve therapeutic drug level of tacrolimus will be assessed in days anddifference in total dose of tacrolimus in different polymorphic patientswill be assessed in mg/day.Timepoint: 3 days, 7 days, 14 days, 1 month, 3 month, 6 month and 12 month | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Raj Kanwar Yadav
All India Institute of Medical Sciences
Outcome results
None listed